The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

September 2022

Additional drugs to have requirements for URMBT members with Blue Cross non-Medicare plans

For dates of service on or after Nov. 1, 2022, the following drugs will require prior authorization through either the NovoLogix® online tool or AIM Specialty Health® and may also have site-of-care requirements, quantity limit requirements or both. These requirements will apply to UAW Retiree Medical Benefits Trust members with Blue Cross non-Medicare plans. The drugs are part of members’ medical benefits, not their pharmacy benefits.

See the table for more information. When a cell is blank, the drug doesn’t have that requirement.

Brand name

Generic name

HCPCS code

HCPCS code

Requirements

Prior authorization

Site of care

Quantity limits

Byooviz®

ranibizumab-nuna

Q5124

NovoLogix

 

 ✓

Carvykti™

ciltacabtagene autoleucel

J9999, C9098

NovoLogix

 

 ✓

Evkeeza™

evinacumab-dgnb

J1305

NovoLogix

 

 ✓

Kimmtrak®

tebentafusp-tebn

J9999, C9095

AIM

 

 

Oxlumo®

lumarisan

J0224

NovoLogix

 

 ✓

Vabysmo®

faricimab-svoa

J3590, C9097

NovoLogix

 

 ✓

Vyvgart®

efgartigimod alfa-fcab

J9332

NovoLogix

 ✓

 

Note: These requirements don’t apply to the UAW Retiree Health Care Trust (group number 70605) or the UAW International Union (group number 71714).

How to submit authorization requests

Submit prior authorization requests through NovoLogix or AIM, as specified above.

If you have access to our provider portal (availity.com**), log in to Availity®, click Payer Spaces and then click the BCBSM and BCN logo. This will take you to the Blue Cross and BCN payer space, where you can click the appropriate tile on the Applications tab.

If you need to request access to Availity, follow the instructions on the Register for webtools webpage at bcbsm.com/providers.

More about the authorization requirements

Authorization isn’t a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for members.

For additional information on requirements related to drugs covered under the medical benefit for URMBT members with Blue Cross non-Medicare plans, see:

We’ll update the pertinent drug lists to reflect the information in this message prior to the effective date.

Note: Accredo manages prior authorization requests for additional medical benefit drugs for these members.

AIM Specialty Health is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to manage authorizations for select services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2021 American Medical Association. All rights reserved.